Skip to main content
FinSpry Logo
FinSpry
BBIO logo
BBIO
(NASDAQ)
BridgeBio Pharma, Inc.
$73.15-- (--)
Loading... - Market loading
OverviewFinancialsForecastStatisticsDividendsHistoricalProfile

BridgeBio Pharma (BBIO) Stock Price & Financial Analysis

BridgeBio Pharma Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$71.95 - $74.63
52-Week High$84.94
52-Week Low$28.33
Open$71.95
Volume1.23M
Average Volume (3M)1.23M
Market Cap14.43B
Shares Outstanding197.24M
Price to Sales (P/S)29.25
EV/EBITDA-28.74
Revenue (TTM)502.08M
Net Income (TTM)-729.31M
Free Cash Flow (TTM)-460.00M
EPS (TTM)$-3.70
Profit Margin-145.26%
Operating Margin-111.31%
50-Day MA$71.63
200-Day MA$61.23
52-Week Change125.47%
Annual Dividend$0.00
Dividend Yield0.00%

Frequently Asked Questions About BridgeBio Pharma

What is the current stock price for BBIO?

As of the latest trading session, BBIO stock trades at $73.15. The 52-week range is $28.33–$84.94, with a day range of $71.95–$74.63.

What is the P/E ratio for BBIO?

The P/E ratio (Price-to-Earnings) for BBIO is shown in the Key Statistics section. This valuation metric helps compare BridgeBio Pharma, Inc. to industry peers.

Does BBIO pay dividends?

BridgeBio Pharma does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for BBIO?

Based on 25 analysts, the consensus for BBIO is Buy. The average 12-month price target is $NaN, representing a NaN% downside from the current price.

What is the market cap of BBIO?

BridgeBio Pharma's market capitalization is $14.43B, classifying it as a large-cap company. BridgeBio Pharma operates in the Healthcare sector within the Biotechnology industry.